Skip to main content

Table 1 The pharmacogenomic landscape of 27 bladder cancer cell lines

From: Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer

Cell Lines Genomic Features Drug Sensitivity
Mut Del Amp Up-reg Down-reg CTRP GDSC CCLE GDBC
5637 1400 117 85 1123 1404 463 98 24 10
639 V 299 135 203 1430 1235 467 99 24 0
647 V 96 342 218 1394 1143 451 99 0 0
BC3C NA 158 37 1298 1277 468 0 0 0
BFTC905 92 549 312 1201 1394 357 99 0 0
CAL29 73 119 637 1151 1420 404 0 0 0
HS172T 47 62 9 1817 1733 0 0 0 0
HT1197 744 113 266 1898 1498 443 99 24 8
HT1376 775 242 455 1583 1614 465 99 24 7
J82 760 324 135 1166 1191 470 95 22 9
JMSU1 96 272 121 1620 1332 463 0 24 0
KMBC2 121 320 122 1496 1616 474 0 24 0
KU1919 91 124 354 1164 1330 461 99 0 0
RT112 903 889 133 1466 1348 442 99 24 0
RT11284 72 163 20 1371 1177 0 0 0 0
RT4 1094 115 30 1458 1384 458 98 24 10
SCABER 85 144 173 1224 1306 455 0 24 0
SW1710 772 161 35 1366 1334 384 99 0 0
SW780 895 187 30 1319 1455 0 99 0 11
T24 NA 121 7 1315 982 473 99 24 8
TCCSUP 720 136 207 2040 1685 467 99 24 0
UBLC1 73 NA NA 1232 1591 467 0 0 0
UMUC1 79 217 331 1928 1591 449 0 0 0
UMUC3 879 175 83 1456 1063 465 95 24 10
VMCUB1 959 128 160 1428 1586 468 99 0 0
253 J 1624 NA NA 1406 1569 410 0 0 4
253 JBV 72 NA NA 1187 1392 377 0 0 12